Autopsy report · NCT02998502

The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens

“minimum subject accrual complete”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months after it had already started.
• Ran for about 4 years 5 months before it stopped.
• 73 participants planned (an estimate, not an actual count).
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Johns Hopkins University

Sponsor type

University, hospital or other

Conditions

Anxiety; Panic Disorder

Interventions

Freespira Breathing System

Participants

73 (planned, not actual)

Sites

1

Countries

United States

Trials that died the same way

• Hydroxyurea for Children and Young Adults With Sickle Cell Disease and Pulmonary Hypertension
  “Low subject accrual” (76% match in meaning)
• Factors Affecting Perioperative Outcomes
  “No subject accrual” (71% match in meaning)
• Evaluation of V.A.C. VERAFLO CLEANSE CHOICE™ Dressing Using Normal Saline to Promote Increased Healthy Wound Bed Tissue
  “Insufficient subject accrual rate” (68% match in meaning)
• Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order
  “Required number of subjects to be included could not be accomplished” (65% match in meaning)
• Impact of Sleep Apnea on Diabetic Foot Wound.
  “Difficulty including subjects corresponding to the criteria.” (60% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.